Mark O. Farber

4.3k total citations
68 papers, 3.0k citations indexed

About

Mark O. Farber is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Mark O. Farber has authored 68 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Critical Care and Intensive Care Medicine and 13 papers in Anesthesiology and Pain Medicine. Recurrent topics in Mark O. Farber's work include Intensive Care Unit Cognitive Disorders (17 papers), Anesthesia and Sedative Agents (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Mark O. Farber is often cited by papers focused on Intensive Care Unit Cognitive Disorders (17 papers), Anesthesia and Sedative Agents (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Mark O. Farber collaborates with scholars based in United States, United Kingdom and Italy. Mark O. Farber's co-authors include Elena Aïkawa, Masanori Aikawa, Malaz Boustani, Edward T. Mannix, F Manfredi, Babar Khan, Noll L. Campbell, Frederick J. Schöen, Frederick J. Schoen and Anthony J. Perkins and has published in prestigious journals such as Circulation, The Journal of Immunology and Cancer.

In The Last Decade

Mark O. Farber

66 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark O. Farber United States 28 1.1k 786 765 441 433 68 3.0k
Bernhard Zwißler Germany 34 1.5k 1.4× 525 0.7× 885 1.2× 384 0.9× 591 1.4× 212 3.9k
David Royston United Kingdom 33 655 0.6× 846 1.1× 896 1.2× 231 0.5× 237 0.5× 132 4.1k
Jeffrey A. Katz United States 34 1.3k 1.2× 361 0.5× 466 0.6× 235 0.5× 1.1k 2.5× 110 3.3k
Mark C. Bellamy United Kingdom 32 430 0.4× 360 0.5× 377 0.5× 180 0.4× 411 0.9× 87 2.9k
Alexander Wahba Norway 27 346 0.3× 576 0.7× 1.3k 1.7× 149 0.3× 147 0.3× 96 3.0k
F.J. Mercier France 36 507 0.5× 409 0.5× 1.2k 1.6× 188 0.4× 418 1.0× 161 4.5k
Lingzhong Meng United States 31 545 0.5× 425 0.5× 988 1.3× 70 0.2× 481 1.1× 110 3.4k
Giuseppe Ristagno Italy 31 501 0.5× 443 0.6× 810 1.1× 223 0.5× 52 0.1× 193 4.2k
Mark R. Elstad United States 18 579 0.5× 397 0.5× 122 0.2× 264 0.6× 220 0.5× 31 1.4k
Michael Fries Germany 30 302 0.3× 637 0.8× 267 0.3× 124 0.3× 252 0.6× 97 2.3k

Countries citing papers authored by Mark O. Farber

Since Specialization
Citations

This map shows the geographic impact of Mark O. Farber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O. Farber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O. Farber more than expected).

Fields of papers citing papers by Mark O. Farber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark O. Farber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O. Farber. The network helps show where Mark O. Farber may publish in the future.

Co-authorship network of co-authors of Mark O. Farber

This figure shows the co-authorship network connecting the top 25 collaborators of Mark O. Farber. A scholar is included among the top collaborators of Mark O. Farber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark O. Farber. Mark O. Farber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Sikandar, Heidi Lindroth, Anthony J. Perkins, et al.. (2020). Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019. Critical Care Explorations. 2(12). e0290–e0290. 41 indexed citations
2.
Campbell, Noll L., Anthony J. Perkins, Babar Khan, et al.. (2019). Deprescribing in the Pharmacologic Management of Delirium (de-PMD): A Randomized Trial in the Intensive Care Unit. PMC. 1 indexed citations
3.
Jacobson, Glenn A., Sharanne Raidal, Morten Hostrup, et al.. (2018). Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed. Drug Safety. 41(5). 441–449. 12 indexed citations
4.
Khan, Babar, Anthony J. Perkins, Sujuan Gao, et al.. (2017). The Confusion Assessment Method for the ICU-7 Delirium Severity Scale: A Novel Delirium Severity Instrument for Use in the ICU. Critical Care Medicine. 45(5). 851–857. 147 indexed citations
5.
Khan, Babar, Anthony J. Perkins, Siu L. Hui, et al.. (2016). Relationship Between African-American Race and Delirium in the ICU. Critical Care Medicine. 44(9). 1727–1734. 27 indexed citations
6.
Khan, Babar, William F. Fadel, W. Graham Carlos, et al.. (2014). Effectiveness of Implementing a Wake Up and Breathe Program on Sedation and Delirium in the ICU. Critical Care Medicine. 42(12). e791–e795. 39 indexed citations
7.
Khan, Babar, et al.. (2013). Interventions to improve the physical function of ICU survivors: a systematic review. PMC. 13 indexed citations
8.
9.
Diab, Khalil, et al.. (2009). A 46-Year-Old Man With Dyspnea and Left Diaphragm Paralysis. CHEST Journal. 136(6). 1690–1693. 3 indexed citations
10.
Aïkawa, Elena, Masanori Aikawa, Mark O. Farber, et al.. (2004). Clinical pulmonary autograft valves: Pathologic evidence of adaptive remodeling in the aortic site. Journal of Thoracic and Cardiovascular Surgery. 128(4). 552–561. 125 indexed citations
11.
Jennings, S. Gregory, Helen T. Winer-Muram, Robert D. Tarver, & Mark O. Farber. (2004). Lung Tumor Growth: Assessment with CT—Comparison of Diameter and Cross-sectional Area with Volume Measurements. Radiology. 231(3). 866–871. 83 indexed citations
12.
Aïkawa, Elena, Mark O. Farber, Masanori Aikawa, & Frederick J. Schöen. (2004). Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.. PubMed. 13(5). 841–7. 289 indexed citations
13.
Mannix, Edward T., et al.. (2003). The Prevalence of Airways Hyperresponsiveness in Members of an Exercise Training Facility. Journal of Asthma. 40(4). 349–355. 29 indexed citations
14.
Caldwell, Charles C., Hidefumi Kojima, Dmitriy Lukashev, et al.. (2001). Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions. The Journal of Immunology. 167(11). 6140–6149. 336 indexed citations
15.
Farber, Mark O.. (1999). Managing community-acquired pneumonia. Postgraduate Medicine. 105(4). 106–114. 7 indexed citations
16.
Mannix, Edward T., Paolo Palange, George R. Aronoff, F Manfredi, & Mark O. Farber. (1990). Atrial natriuretic peptide and the renin-aldosterone axis during exercise in man. Medicine & Science in Sports & Exercise. 22(6). 785–785. 27 indexed citations
17.
Farber, Mark O., Myron H. Weinberger, Gary L. Robertson, & Naomi S. Fineberg. (1987). The Effects of Angiotensin-Converting Enzyme Inhibition on Sodium Handling in Patients with Advanced Chronic Obstructive Pulmonary Disease. American Review of Respiratory Disease. 136(4). 862–866. 21 indexed citations
18.
Farber, Mark O., Myron H. Weinberger, Gary L. Robertson, Naomi S. Fineberg, & F Manfredi. (1984). Hormonal Abnormalities Affecting Sodium and Water Balance in Acute Respiratory Failure Due to Chronic Obstructive Lung Disease. CHEST Journal. 85(1). 49–54. 38 indexed citations
19.
Farber, Mark O., et al.. (1982). The Effect of Hemodialysis on Oxygen Transport in Chronic Uremics. The American Journal of the Medical Sciences. 283(2). 50–56.
20.
Einhorn, Lawrence H., et al.. (1976). Improved chemotherapy for small-cell undifferentiated lung cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 235(12). 1225–9. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernhard Zwißler Breakdown of academic impact, for papers by David Royston Breakdown of academic impact, for papers by Jeffrey A. Katz Breakdown of academic impact, for papers by Mark C. Bellamy Breakdown of academic impact, for papers by Alexander Wahba Breakdown of academic impact, for papers by F.J. Mercier Breakdown of academic impact, for papers by Lingzhong Meng Breakdown of academic impact, for papers by Giuseppe Ristagno Breakdown of academic impact, for papers by Mark R. Elstad Breakdown of academic impact, for papers by Michael Fries
Rankless by CCL
2026